|
CANCER OF THE URINARY TRACT
Case Histories
include Cancer of the Bladder
Between 57 and 90 out of every 100
patients with cancer of the bladder
who do not choose Laetrile but
choose orthodox treatment instead
will be dead within five years(1).
Orthodox treatment has many serious
and painful side effects. It is
important to consider these facts
while reading the following Laetrile
case histories.
E148M: Cancer of the Bladder,
Previous Cancer of the Cervix
Mrs.
E. was forty-eight years old in
September, 1972, when she was
diagnosed as having "poorly
differentiated invasive endocervical
carcinoma." Uterine curettings
revealed adenocanthoma. Bilateral
inguinal node biopsies, September
15, 1972, were negative.
An
examination of the cervix revealed
it to be hard and irregular and
largely replaced by necrotic tumor.
The radiologist stated, "1 think
there is medial parametrial
involvement." (‘This means he
thought the cancer had also gone
into the tissue and smooth muscle
around the uterus.)
In a
letter dated September 22, 1972, the
patient’s physician—the radiologist
from St. Joseph’s Hospital in
Stockton, California, explained:
(1)Clinical Oncology for Medical
Students and Physicians, op. cit.,
p. 202.
I plan
3500 rads whole pelvis radiation. I
may possibly give an additional 500
rads to the left parametrial area.
This will then probably be followed
by 5000 to 5500 mg hours in two
separate radium application.
She
understands that complications may
occur in spite of precautions. I
also told her that chances were
reasonably good, but that a cure
could in no way be guaranteed. She
understands these issues quite well
I think.
The
patient was treated with cobalt60
and radium implant therapy from
September through December, 1972,
for her Stage II cervical cancer.
Two
years later, July, 1974, the patient
was referred by her gynecologist to
a urologist in Stockton, California,
because of blood in her urine.
The
bladder had a lesion which, in the
opinion of the urologist was cancer.
No treatment was recommended
according to the patient—perhaps
because of the extensive radiation
the area had already received. The
patient states she was given a few
months, at most, to live.
Mrs.
E., a widow and a grandmother, was
"putting her affairs in order" when
a salesman came to her door with a
multi-volume children’s Bible set.
The patient was impressed with the
series and wanted to purchase it for
her grandchildren. She explained to
the salesman she could not purchase
the Bibles despite her wish to do so
because there was very little chance
she would be alive long enough to
complete the time payments.
Mrs.
E. told the salesman that she was
dying of cancer. He asked her if she
had heard of Laetrile, and when the
patient said no, the salesman left
and returned several hours later
with books on Laetrile for Mrs. E.
to read.
The
material she read, combined with the
hopelessness of her situation under
orthodox therapy, led Mrs. E. to
make an appointment at the
Richardson Clinic and begin a course
of metabolic therapy including
Laetrile on August 7, 1974.
The
patient responded beautifully, as is
evidenced by the comments of her
urologist in a letter to the
Richardson Clinic dated November 19,
1975, (sixteen months after she had
been pronounced terminal). The
letter reads in part as follows:
I saw
Mrs. B. initially in referral from
her gynecologist on July 15, 1974.
concerning bladder irritative
symptoms and gross hematuria of
several days duration.
Office
cystourethroscopy [visualizing the
inside of the bladder by instrument]
on July 22, 1974, disclosed a
fungating bleeding posterior urinary
bladder floor lesion that had all
the appearances of tumor extension,
while she had a low capacity urinary
bladder undoubtedly associated with
some delayed radiation cystitis.
The
lesion had the appearance of
neoplasm in my sixteen years of
experience. Mrs. B. returned on
November 12, 1974, requesting repeat
cystoscopy and at that time, the
patient was having gross hematuria
(blood in the urine) with a few
clots each morning and had been
receiving medication from you
[Richardson Clinic] for
approximately three months...
Mrs.
B. returned on November 17, 1975,
with a "tugging" type of discomfort
in her mid-pelvic region. She had
had no gross hematuria for
approximately one year. Repeat
cystourethroscopy showed no urinary
bladder floor lesions at this time,
although there was a whitish area
where the original lesion had been
and one could see the definite
outline of same. It appeared to
represent some type of smooth and
glistening scar tissue. Repeat
pelvic examination again
demonstrated definite tenderness and
even more vaginal stenosis [due to
previous radiation]. A bimanual
rectal examination failed to
disclose exidence of masses beyond
the area of the cervix and urinary
bladder floor.... Needless to say, I
was most happy with Mrs. E.’s
current situation and wished her the
best of luck.
B104G: Recurrent Cancer of the
Bladder
This
man was sixty-three years old at the
time he first sought medical
treatment for blood in his urine. In
October, 1974, he was X-rayed,
cystoscoped (viewing of the
bladder), and the tumors in his
bladder were removed. The pathology
report identified the tissue as
"papillary type transitional cell
carcinoma of the bladder, grade I to
II." The surgery report states
approximately 8-10 gm. of tissue was
removed.
Three
weeks later, surgery was performed,
and additional cancerous tumor was
removed. The patient, an investment
counselor who lives near St. Louis,
Missouri, was strongly urged to have
his bladder removed. He was
unwilling to submit to this surgery,
so radiation was scheduled.
He
received 6500 rads of cobalt during
a fifty-seven-day period between
November 26, 1974, and January 15,
1975. During this time the patient
described himself as weak, listless,
subjected to intense abdominal
cramping, and as passing cloned and
fresh blood in his urine. Also,
during this same period he had to be
hospitalized because of acute
urinary retention.
May,
1975, four months after the
completion of radiation treatments,
surgery was again required to remove
more cancerous tumor.
In
November, 1975, for the second time
since the radiation therapy, it was
necessary to remove additional
cancerous tumors. At this point, the
patient stated, "The doctor
concluded at this time that I should
be examined every ninety days. To
me, this Was an ominous sign, and I
decided on vitamin therapy without
further delay."
Mr. B.
began metabolic therapy including
Laetrile on January 15, 1976. He
stated he has been conscientious
about taking all the vitamins and
has adhered strictly to the
vegetarian diet. This is not an easy
regimen for an individual who must
eat frequently away from home.
Mr. B.
was examined again by his local
doctor on March 15, 1976, and the
patient stated that three small
clusters of grade II carcinoma were
found. Eight months later he was
examined again and advised that the
cancer was no longer progressing.
It is
important to restate the fact that,
during the eleven months of
"orthodox" therapy, five
hospitalizations were required plus
fifty-seven days of the out-patient
treatment for cobalt therapy. Two of
the surgeries were subsequent to the
cobalt treatment.
During
the twelve months of maintenance
therapy on Laetrile, his only other
medical expenses were for two
cystoscopic exams from his local
doctor(1)
In a
letter to the Richardson Clinic
dated January 5, 1977 (one year
following the beginning of metabolic
therapy), Mr. B. concluded:
I have
been under your treatment and have
followed your recommended diet for a
year and, quite frankly, I have
never felt better nor bad more
energy. I submitted to cystoscopic
examination in late November, 1976,
and there was no apparent cancer
progress. I was discharged from the
hospital in record time.
I
expect to continue your recommended
treatment and diet for the remainder
of my life, and we pray that nothing
may happen to impede you in your
work..
(1)
The medical bills were vastly
different under the two modalities
(consensus medicine vs. metabolic
therapy). Are there any insurance
companies out there which would care
to join our crusade for metabolic
therapy?
H143E:
Cancer of the Bladder
This
man was fifty-eight years old when
he first began to develop cancerous
bladder tumors in 1971.
(He
had a previous history of squamous
cell carcinoma of the lip. It was
resected in 1965.)
In
August, 1971, Mr. H. began to pass
blood in his urine. Subsequent
examination revealed cancer of the
bladder "Grade IV, Stage A
transitional cell carcinoma." The
tumors were removed, along with part
of the bladder.
His
symptoms returned a year later.
Admission history from St. Mary’s
Hospital in Reno, Nevada, dated June
22, 1973, states in part:
The
patient was seen initially by me in
August, 1972, with gross hematuria
[blood m the urine].... The patient
was scoped by me and was noted to
have recurrence of tumor. This was
resected. The pathology showed
transition cell CA [cancer] Grade
III to IV in multiple sites. He was
brought back for one more resection,
again Grade III CA... in addition...
a prostate resection.... September,
1972, patient was noted to have
microscopic foci of well
differentiated adenocarcinoma. . .
The patient completed his
radiotherapy [5,400 rads] around
February of this year [1973].
The
fourth bladder surgery was performed
on lime 26, 1973 (four months
following radiation). Multiple
bladder biopsies were taken and then
the two areas of cancer were
fulgurated (burning of tissue by
means of high frequency electric
sparks). Pathology report stated the
tissue received was "transitional
carcinoma (cancer), Grade II."
November 19, 1973, the patient’s
bladder was again examined. Two
areas of tumor were found. The
patient’s records from the Nevada
hospital do not state what
specifically was done about the
tumors identified in November, 1973.
The
patient again developed blood in the
urine late in 1974. He states that
the doctor advised him he could not
receive any more radiation because
he had already received the maximum
allowable.
Apparently, the only thing that was
done for the patient was to put him
on Percodan for the pain. There was
some question of inguinal gland
involvement in cancer, and the
patient also developed pain in his
right hip. Lymphangiograms done at
the time were inconclusive because
of previous radiation to the area.
This
man concluded that he had exhausted
all possibilities with conventional
therapy, so he turned to metabolic
therapy including Laetrile. This was
begun January 16, 1975.
Within
two weeks he was no longer requiring
the pain-killer Percodan, and
instead of regularly passing large
red clots of blood in his urine he
was passing only occasional tiny
clots, which he states were the size
of a "match head".
The
patient has continued on his
maintenance dose of vitamins and, at
the time of this report, was
essentially symptom-free. This
represents a two-year absence of
bladder problems while on Laetrile.
(A previous two-year period between
August, 1971, and August, 1973,
required four surgeries and 5,400
rads of radiation—at the conclusion
of which the patient still had
tumors of the bladder, blood in his
urine, and the need for the
pain-killer Percodan.)
A141JA: Cancer of the Bladder
This
man was sixty-four years old at the
time he went to his local doctor in
October of 1974 because of
discomfort in the area of the
bladder. Physical examination
revealed an enlarged prostate.
On
October 21, 1974, the surgeon
performed a transurethral removal of
the prostate gland and a bladder
tumor. Post-operative diagnosis was
papillary carcinoma (cancer) of the
urinary bladder and benign prostate
hypertrophy (non-cancerous
enlargement of the prostate gland).
Cystoscopic examination of the
bladder was performed on February
18, 1975, and June 17, 1975. The
physician’s summary stated:
The
first tumor was posterior to the
original resected area, and another
small area was noted anteriorly at
the bladder neck. These tumors had
increased in size from February 18
to June 17 of this year.
Because this man had experienced a
return of tumors following removal
of the first cancer, he decided to
seek metabolic treatment as an
alternative to further surgery. He
began metabolic therapy on July 22,
1975. Our last contact with this
patient was in January, 1977, one
and one-half years later. At that
time he was maintaining his
therapeutic program, was
symptom-free, and it appeared his
cancer was controlled.
C134CR: Cancer of the Bladder
This
seventy-two-year-old woman has an
extensive history of surgeries, most
of which have been for cancer.
1).
1948—Removal of the uterus and
ovaries, reason not dear to patient.
Records not available.
2).
1959—Removal of left breast for
cancer.
3).
1967—Bladder surgery: Polyp removal.
4).
1968—Colon surgery: Thirteen inches
of malignant colon removed. Was told
she might have five more years to
live.
5).
1971—Bladder surgery.
6).
1973—Bladder surgery: Patient was
told next surgery would require its
removal.
7).
June, 1975—Bladder surgery to repair
damage from previous examination.
Malignancy found. Patient was told
it was inoperable. Radiation and
chemotherapy were urged by the
doctor. Both were refused by the
patient.
Mrs.
C., who is a practicing lawyer,
reflected on her medical problems in
this way.
I felt
whipped down by these continual
operations, and wondered why, with
all the expenditure of money for
investigation, no cause of, or
remedy for, cancer had ever been
found. It seemed to me that the
doctors were only removing symptoms;
no one had any suggestions as to why
the cancer continued to recur.
The
patient states she heard about
vitamin therapy through friends in
Oakland, who suggested she contact
Dr. Richardson. Vitamin therapy was
begun in March of 1975. It will be
noted that this was two months
before the last discovery of cancer.
That does not invalidate the case,
however, for it took more than two
months for that bladder cancer to
develop, and the usual pattern for
regression of any cancer (that is to
say the lump itself) in the
experience of this clinic, is that
the regression is steady but slow.
It should be emphasized, however,
that the concern of the clinic is
not the lump but the total
physiological milieu of the patient.
This is in stark contrast to the
lump-oriented thinking of orthodoxy,
which says it does not matter much
how the patient looks or feels as
long as something is done about the
lump.
Mrs.
C. had been on metabolic therapy for
a year at the time of our last
contact with her. She stated her
life has "entirely changed." She has
discussed the use of metabolic
therapy with her local doctor, who
continues to remain noncommittal.
She stays on the diet faithfully,
with the exception of variations
necessary because she also has
hypoglycemia. She continues to take
the suggested supplements.
In a
letter postmarked March 28, 1976,
the patient commented on the impact
of vitamin therapy and on the
quality of her life in these words:
There
has been no need for further
operations; I feel better than I did
at the age of forty and I’m now
seventy-two. I am a retired lawyer
who now serves on numerous public
and church commissions and
committees; I do gardening on an
acre and a quarter of lovely garden
and orchard; I am an organist in a
Rescue Mission Chapel; I travel
extensively, and still give legal
aid when called upon by clients or
the local bar association.
And
that is quite a schedule for a
seventy-two-year-old lady with a
long history of cancer! |
